BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28395797)

  • 1. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
    Hansen M; Varga E; Wüst T; Brouwer N; Beauchemin H; Mellink C; van der Kevie-Kersemaekers AM; Möröy T; van der Reijden B; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of human iPSC lines SANi001-A and SANi002-A from mobilized peripheral blood derived megakaryoblasts.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Dec; 25():42-45. PubMed ID: 29055227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.
    Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
    Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
    Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
    Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
    Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a rabbit induced pluripotent stem cell (RbiPSC) line using lentiviral delivery of human pluripotency factors.
    Táncos Z; Nemes C; Varga E; Bock I; Rungarunlert S; Tharasanit T; Techakumphu M; Kobolák J; Dinnyés A
    Stem Cell Res; 2017 May; 21():16-18. PubMed ID: 28677530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies.
    Telliam G; Féraud O; Griscelli F; Opolon P; Divers D; Bennaceur-Griscelli A; Turhan AG
    Stem Cell Res; 2016 Sep; 17(2):235-237. PubMed ID: 27879209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human induced pluripotent stem cells in defined, feeder-free conditions.
    Kyrkou A; Stellas D; Syrrou M; Klinakis A; Fotsis T; Murphy C
    Stem Cell Res; 2016 Sep; 17(2):458-460. PubMed ID: 27879223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).
    Maguire JA; Lu L; Mills JA; Sullivan LM; Gagne A; Gadue P; French DL
    Stem Cell Res; 2016 Mar; 16(2):233-5. PubMed ID: 27345974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
    Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.
    Warlich E; Kuehle J; Cantz T; Brugman MH; Maetzig T; Galla M; Filipczyk AA; Halle S; Klump H; Schöler HR; Baum C; Schroeder T; Schambach A
    Mol Ther; 2011 Apr; 19(4):782-9. PubMed ID: 21285961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.